112 related articles for article (PubMed ID: 17402364)
1. Chloroquine treatment reduces the number of cutaneous HLA-DR+ and CD1a+ cells in patients with systemic lupus erythematosus.
Wozniacka A; Lesiak A; Narbutt J; Kobos J; Pavel S; Sysa-Jedrzejowska A
Lupus; 2007; 16(2):89-94. PubMed ID: 17402364
[TBL] [Abstract][Full Text] [Related]
2. [The influence of ultraviolet radiation on HLA-DR+ and CD1a+ cells' number in systemic lupus erythematosus patients].
Lesiak A; Narbutt J; Kobos J; Sysa-Jedrzejowska A; Woźniacka A
Przegl Lek; 2007; 64(9):563-7. PubMed ID: 18510077
[TBL] [Abstract][Full Text] [Related]
3. The influence of antimalarial treatment on IL-1beta, IL-6 and TNF-alpha mRNA expression on UVB-irradiated skin in systemic lupus erythematosus.
Wozniacka A; Lesiak A; Boncela J; Smolarczyk K; McCauliffe DP; Sysa-Jedrzejowska A
Br J Dermatol; 2008 Nov; 159(5):1124-30. PubMed ID: 18764842
[TBL] [Abstract][Full Text] [Related]
4. Effect of chloroquine phosphate treatment on serum MMP-9 and TIMP-1 levels in patients with systemic lupus erythematosus.
Lesiak A; Narbutt J; Sysa-Jedrzejowska A; Lukamowicz J; McCauliffe DP; Wózniacka A
Lupus; 2010 May; 19(6):683-8. PubMed ID: 20064914
[TBL] [Abstract][Full Text] [Related]
5. Chloroquine treatment influences proinflammatory cytokine levels in systemic lupus erythematosus patients.
Wozniacka A; Lesiak A; Narbutt J; McCauliffe DP; Sysa-Jedrzejowska A
Lupus; 2006; 15(5):268-75. PubMed ID: 16761500
[TBL] [Abstract][Full Text] [Related]
6. Antimalarials and cholesterol profile of patients with systemic lupus erythematosus.
Rossoni C; Bisi MC; Keiserman MW; Staub HL
Rev Bras Reumatol; 2011; 51(4):383-4, 386-7. PubMed ID: 21779713
[TBL] [Abstract][Full Text] [Related]
7. The circulating lymphocyte profiles in patients with discoid lupus erythematosus and systemic lupus erythematosus suggest a pathogenetic relationship.
Wouters CH; Diegenant C; Ceuppens JL; Degreef H; Stevens EA
Br J Dermatol; 2004 Apr; 150(4):693-700. PubMed ID: 15099365
[TBL] [Abstract][Full Text] [Related]
8. Decrease in HLA-DR-positive monocytes in patients with systemic lupus erythematosus (SLE).
Shirakawa F; Yamashita U; Suzuki H
J Immunol; 1985 Jun; 134(6):3560-2. PubMed ID: 3857279
[TBL] [Abstract][Full Text] [Related]
9. In situ localization of chloroquine and immunohistological studies in UVB-irradiated skin of photosensitive patients.
Sjölin-Forsberg G; Berne B; Eggelte TA; Karlsson-Parra A
Acta Derm Venereol; 1995 May; 75(3):228-31. PubMed ID: 7653184
[TBL] [Abstract][Full Text] [Related]
10. Controlled trial with chloroquine diphosphate in systemic lupus erythematosus.
Meinão IM; Sato EI; Andrade LE; Ferraz MB; Atra E
Lupus; 1996 Jun; 5(3):237-41. PubMed ID: 8803897
[TBL] [Abstract][Full Text] [Related]
11. HLA-G genotype and HLA-G expression in systemic lupus erythematosus: HLA-G as a putative susceptibility gene in systemic lupus erythematosus.
Rizzo R; Hviid TV; Govoni M; Padovan M; Rubini M; Melchiorri L; Stignani M; Carturan S; Grappa MT; Fotinidi M; Ferretti S; Voss A; Laustrup H; Junker P; Trotta F; Baricordi OR
Tissue Antigens; 2008 Jun; 71(6):520-9. PubMed ID: 18380776
[TBL] [Abstract][Full Text] [Related]
12. Exacerbations of bipolar disorder triggered by chloroquine in systemic lupus erythematosus--a case report.
Bogaczewicz J; Sobów T; Bogaczewicz A; Robak E; Bienkowski P; Sysa-Jedrzejowska A; Wozniacka A
Lupus; 2014 Feb; 23(2):188-93. PubMed ID: 24297641
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic modulation of RFC1, MHC2TA and HLA-DR in systemic lupus erythematosus: association with serological markers and six functional polymorphisms of one-carbon metabolic pathway.
Rupasree Y; Naushad SM; Rajasekhar L; Kutala VK
Gene; 2014 Feb; 536(1):45-52. PubMed ID: 24333266
[TBL] [Abstract][Full Text] [Related]
14. The cardiac safety of chloroquine phosphate treatment in patients with systemic lupus erythematosus: the influence on arrhythmia, heart rate variability and repolarization parameters.
Wozniacka A; Cygankiewicz I; Chudzik M; Sysa-Jedrzejowska A; Wranicz JK
Lupus; 2006; 15(8):521-5. PubMed ID: 16942005
[TBL] [Abstract][Full Text] [Related]
15. Low expression of human histocompatibility leukocyte antigen-DR is associated with hypermethylation of human histocompatibility leukocyte antigen-DR alpha gene regions in B cells from patients with systemic lupus erythematosus.
Sano H; Compton LJ; Shiomi N; Steinberg AD; Jackson RA; Sasaki T
J Clin Invest; 1985 Oct; 76(4):1314-22. PubMed ID: 2997276
[TBL] [Abstract][Full Text] [Related]
16. Peptides from antibodies to DNA elicit cytokine release from peripheral blood mononuclear cells of patients with systemic lupus erythematosus: relation of cytokine pattern to disease duration.
Kalsi JK; Grossman J; Kim J; Sieling P; Gjertson DW; Reed EF; Ebling FM; Linker-Israeli M; Hahn BH
Lupus; 2004; 13(7):490-500. PubMed ID: 15352419
[TBL] [Abstract][Full Text] [Related]
17. Diminished peripheral blood monocyte DR antigen expression in systemic lupus erythematosus.
Nagai H; Sztein MB; Steeg PS; Hooks JJ; Oppenheim JJ; Steinberg AD
Clin Exp Rheumatol; 1984; 2(2):131-7. PubMed ID: 6598101
[TBL] [Abstract][Full Text] [Related]
18. Impact of Therapy on Metabolic Syndrome in Young Adult Premenopausal Female Lupus Patients: Beneficial Effect of Antimalarials.
Muniz LF; Pereira RMR; Silva TF; Bonfá E; Borba EF
Arthritis Care Res (Hoboken); 2015 Sep; 67(9):1255-1262. PubMed ID: 25832035
[TBL] [Abstract][Full Text] [Related]
19. [Chloroquine influence on lipid metabolism and selected laboratory parameters].
Woźniacka A; Lesiak A; Smigielski J; Sysa-Jedrzejowska A
Przegl Lek; 2005; 62(9):855-9. PubMed ID: 16541717
[TBL] [Abstract][Full Text] [Related]
20. Antimalarials in the treatment of systemic lupus erythematosus: a registry-based cohort study in Denmark.
Nørgaard JC; Stengaard-Pedersen K; Nørgaard M; de Thurah A
Lupus; 2015 Mar; 24(3):299-306. PubMed ID: 25318969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
